Jeremy Veenstra-VanderWeele Archives
Mar. 27, 2014—A Center for Medicine, Health and Society forum titled "The Politics of Childhood Vaccines" is set for April 9 in Light Hall.
Aug. 22, 2013—"Vanderbilt's Nobel Prize," the Earl Sutherland Prize for achievement in research, was awarded to John Gore at the Fall Faculty Assembly, while Gordon Bernard received the Thomas Jefferson Award for distinguished service to Vanderbilt.
May. 23, 2013—Vanderbilt University is part of a multi-site autism clinical study designed to evaluate the effectiveness of a blood test that aims to screen children for referral for autism spectrum disorder evaluation (ASD) earlier and more accurately.
May. 9, 2013—Researchers at Vanderbilt University have received grant awards from the National Institutes of Health as part of the Autism Centers of Excellence (ACE) research program. The NIH announced grant awards of $100 million over five years to 11 centers nationwide, three of which feature projects from Vanderbilt Kennedy Center investigators, to further studies on autism treatment and intervention.
Nov. 15, 2012—Randy Blakely, Ph.D., left, shares a laugh with Jeremy Veenstra-VanderWeele, M.D., and Elisabeth Dykens, Ph.D., at the fifth annual Conte Center Symposium, held recently in the Vanderbilt Law School’s Flynn Auditorium. Entitled “The Younger Games: Serotonin Science Comes of Age,” the symposium featured presentations by an international group of researchers.
Sep. 24, 2012—Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population.
Aug. 27, 2012—There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism.
Mar. 30, 2012—Autism experts from Vanderbilt University are available for interviews on World Autism Awareness Day, designated by the United Nations as April 2.
Mar. 20, 2012—A genetic variation that causes early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder and other enduring effects on behavior.
Apr. 4, 2011—Although an evaluation of existing treatments for children with autism spectrum disorders found positive results in some studies, better information is needed to target the right treatments to specific children.